HIV Infections: all 4,342 studies
Page 22 of 44. Open to participants first (242), then studies with results posted, then the rest; newest registration first within each.
- Microboosting of Atazanavir 300 mg With 50 mg Versus 100mg Ritonavir Daily in HIV-infected Patients: a Pharmacokinetic StudyCompletedNCT02034838Phase 1
- An Evidence Based Smoking Cessation Program for Persons Living With HIV/AIDS (Project Legacy)WithdrawnNCT02029612Not applicable
- Compassionate Use of Ibalizumab for the Treatment of HIV InfectionNo longer availableNCT02028819
- Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral TherapyCompletedNCT02028403Phase 1
- Enhanced HIV Prevention in Couples: Feasibility Study #1CompletedNCT02027714
- Enhanced HIV Prevention in Couples: Feasibility Study #3CompletedNCT02027519
- Antiretroviral Therapy and Inflammatory and Coagulation Biomarkers: iMACS StudyCompletedNCT02027480
- Study to Evaluate the Effect of GSK1265744 on Cardiac ConductionCompletedNCT02027454Phase 1
- Enhanced Prevention in Couples: Feasibility Study #2CompletedNCT02027441
- Third Line Antiretroviral Treatment Optimization in Sub-Saharan AfricaStatus unknownNCT02025868Phase 2
- A Pilot Study to Examine Efficacy of Peer Mentoring in Promoting Medication Adherence Among People Living With HIV/AIDSStatus unknownNCT02025322Not applicable
- Gonorrhea and Chlamydia HIV-infected Men Who Have Sex With MenCompletedNCT02019771
- Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIVActive, not recruitingNCT02016924Phase 2/3
- The Use of Peer Referral Incentives to Increase Demand for Voluntary Medical Male Circumcision in ZambiaCompletedNCT02012816Not applicable
- Novel Therapy for Glucose Intolerance in HIV DiseaseCompletedNCT02006914
- Multi-level Determinants of Starting ART Late: Aim 3CompletedNCT01997359
- Multi-level Determinants of Starting ART Late: Aim 2CompletedNCT01997346
- Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01), Administered Intravenously or Subcutaneously to Healthy AdultsCompletedNCT01993706Phase 1
- Interaction Between High Dose Rifampicine and Efavirenz in Pulmonary Tuberculosis and HIV Co-infectionStatus unknownNCT01986543Phase 2
- Pharmacokinetic (PK) Study of Twice Daily vs Once Daily Lamivudine (3TC) and Abacavir (ABC) as Part of Combination Antiretroviral Therapy (ART) in HIV Infected ChildrenCompletedNCT01982396Phase 1
- Safety, Tolerability, Drug Interactions, and Antiviral Activity of Rilpivirine in Antiretroviral-Naive HIV-Infected Children Less Than 12 Years of AgeWithdrawnNCT01975012Phase 1/2
- Evaluating the Safety and Immune Response to Three Different Prime-Boost HIV Vaccine Regimens in Healthy, HIV-Uninfected AdultsWithdrawnNCT01970449Phase 1
- Effect of Carbamazepine on Dolutegravir Pharmacokinetics in Healthy Adult SubjectsCompletedNCT01967771Phase 1
- Observational Study of HIV-associated Neurocognitive DisorderCompletedNCT01966094
- Evaluating the Safety and Immune Response to Five Different Combinations of HIV Vaccines in Healthy, HIV-Uninfected AdultsWithdrawnNCT01964937Phase 1
- Mother Infant Retention for Health: MIR4HealthCompletedNCT01962220Not applicable
- Gene Therapy After Frontline Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin LymphomaActive, not recruitingNCT01961063Phase 1
- Evaluation of Safety and Efficacy of the PrePexTM Device for Rapid Scale up of Adult MC Programs in ZimbabweCompletedNCT01956396Phase 1
- Feasibility of Using a Structured Daily DiaryCompletedNCT01953653Not applicable
- X-linked Biological Response to HIV Sensing: the ANRS EP 53 StudyCompletedNCT01952587Not applicable
- IL-23/IL-12 Imbalance and T Lymphocyte Polarization in HIV InfectionCompletedNCT01942655Not applicable
- A Phase 1, Randomized, Blinded, Dose-escalation Study of rAAV1-PG9DP Recombinant AAV Vector Coding for PG9 Antibody in Healthy Male Adults.Status unknownNCT01937455Phase 1
- Study of Immune Responses Induced by a HIV VaccineStatus unknownNCT01933685Phase 2
- At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsCompletedNCT01931644
- Study of Boosting Strategies After Vaccination With ALVAC-HIV and AIDSVAX® B/EStatus unknownNCT01931358Phase 2
- Evaluating the Safety and Immune Response to Two HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults in the United States and South AfricaWithdrawnNCT01927835Phase 1
- RCT of an Integrative Intervention for Non-Treatment-Seeking Meth UsersCompletedNCT01926184Not applicable
- HBV-HIV Coinfection Research NetworkCompletedNCT01924455
- Safety and Immunological Response of a Boosting Dose of MVA-B in Healthy Volunteers After 4 Years of Receiving MVA-BCompletedNCT01923610Phase 1
- Early Identification and Treatment of Early HIV Infection in Côte d'IvoireCompletedNCT01917175
- Differences in Response to the Flu Vaccine Among Adults With HIV and Without HIV in UgandaCompletedNCT01916759Not applicable
- Adapting and Evaluating an EBI to Prevent HIV/AIDS Risk Among Apache YouthCompletedNCT01910714Not applicable
- Evaluating the Safety and Immune Response of DNA/MVA Vaccines in HIV-1-Infected Young Adults Taking Anti-HIV MedicationsWithdrawnNCT01909414Phase 1
- Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life ConditionsCompletedNCT01908660
- Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in AfricaCompletedNCT01905059Phase 3
- Link4Health: A Combination Strategy for Linkage and Retention, SwazilandCompletedNCT01904994Not applicable
- Multi-component HIV Intervention Packages for Chinese Men Who Have Sex With Men -Test, Link and Care (TLC)CompletedNCT01904877
- A Prospective, Open-label Trial of Two ABC/3TC Based Regimens in Late Presenter naïve Patients (CD4 <200 Cells/µL)CompletedNCT01900106Phase 3
- Epicardial Adipose Tissue And Coronary Risk In HIV-Infected PatientsCompletedNCT01899196Not applicable
- Nutritional Status Among naïve HIV Infected Patients and HIV Infected Patients Receiving Highly Active Antiretroviral TherapyCompletedNCT01899157
- Viral Biofilms: Hijacking T Cell Extracellular Matrix to Regulate HIV-1 Spread?CompletedNCT01895920Not applicable
- Swaziland Safe GenerationsCompletedNCT01891799
- Use of the Shang Ring Circumcision Device in Boys Below 18 Years Old in KenyaCompletedNCT01891409Not applicable
- EFV Pharmacokinetics & Pharmacogenomics in Older HIV-infected PatientsCompletedNCT01886404
- Opioid Relapse & HIV Risk: 48 Versus 24 Weeks of Injectable Extended Release NaltrexoneCompletedNCT01882361Phase 2/3
- Safety and Immunogenicity of Recombinant HIV Vaccines for HIV/AIDSStatus unknownNCT01881581Phase 1
- Diagnosis and Treatment of Co-infection With Human Immunodeficiency Virus /Latent Tuberculosis Infection (HIV/TBL)Status unknownNCT01875952Phase 4
- Severe Impairment of Solute-Free Water Clearance in Patients With HIV InfectionCompletedNCT01869010
- Switching Undetectables to SelzentryCompletedNCT01866267Phase 4
- A Prospective, Observational, Drug Utilization Study of Subjects Taking Truvada for Pre-exposure Prophylaxis in the USACompletedNCT01865799
- A Prospective, Observational Study of Pregnancy Outcomes Among Women Exposed to Truvada for PrEP IndicationCompletedNCT01865786
- Using Multimedia Technologies to Disseminate an HIV PreventionCompletedNCT01863537Not applicable
- Evaluating a Microfinance Intervention for High Risk Women in MongoliaCompletedNCT01861431Not applicable
- Evaluation of Barriers to Postpartum Care in HIV Infected WomenCompletedNCT01853917
- Seek, Test, Treat, Retain: An Integrated Jail-Prison-Community Model for IllinoisCompletedNCT01852877
- A Phase 4 Cross-Sectional Study of Bone Mineral Density in HIV-1 Infected SubjectsCompletedNCT01850212
- Evaluating Rewards-Based Adherence and Electronic Medication Monitoring in HIV-Positive AdolescentsCompletedNCT01849393
- Immune Activation and Drug Absorption in HIV-Infected PatientsCompletedNCT01845298Not applicable
- The Self-Collection Study: a Study of Self-collected HPV Testing and Results CounselingCompletedNCT01843478Not applicable
- Randomized Placebo-controlled Pilot Trial of Prebiotics+Glutamine in HIV InfectionCompletedNCT01838915Phase 1/2
- An Intervention to Improve Antenatal Access to CD4 Testing and HAART in BotswanaCompletedNCT01836003Not applicable
- Metabolomics Fingerprinting and Metabolic Dynamics After HIV InfectionStatus unknownNCT01828268
- Study of Dolutegravir (DTG) on PK of Cenicriviroc (CVC), and CVC on PK of DTG & on a Single Dose of MidazolamCompletedNCT01827540Phase 1
- Prevention of HIV Infection in High-Risk Social Networks of African American Men Who Have Sex With Men (MSM)CompletedNCT01825252Not applicable
- Reduction of EArly mortaLITY in HIV-infected Adults and Children Starting Antiretroviral TherapyCompletedNCT01825031Phase 3
- Pharmacokinetic Interactions Between Telaprevir and Un-boosted AtazanavirCompletedNCT01818856Phase 1
- Immunogenicity and Safety of Trivalent Influenza Vaccine in Non-pregnant HIV-infected WomenCompletedNCT01812980Phase 4
- Antiretroviral Therapy and Extreme WeightCompletedNCT01805427
- Single Dose Escalation Study of GSK2838232 in Healthy SubjectsCompletedNCT01802918Phase 1
- Evaluating the Safety and Priming Response of an HIV Vaccine Regimen in Healthy, HIV-Uninfected AdultsCompletedNCT01799954Phase 1
- Trial of Vitamin D in HIV ProgressionCompletedNCT01798680Phase 3
- DRV/r + RPV QD: Efficacy and Toxicity ReductionCompletedNCT01792570Phase 3
- Clinic-based ART Diagnostic EvaluationCompletedNCT01791556Not applicable
- Evaluating the Safety and Immune Response to Three HIV Vaccine Schedules in Healthy, HIV-Uninfected AdultsCompletedNCT01783977Phase 1
- Mater-Bronx Rapid HIV Testing Project.Status unknownNCT01778374Not applicable
- An Expanded Access Protocol for Subjects Who Have Completed Clinical Studies Involving MaravirocNo longer availableNCT01776996
- Palliative Care in People Living With HIV/AIDS: Integrating Into Standard of CareCompletedNCT01775436Not applicable
- Folinic Acid and Vascular Reactivity in HIVCompletedNCT01768182Not applicable
- A Study to Evaluate the Effects of Calcium Carbonate and Ferrous Fumarate on Pharmacokinetics of Dolutegravir in Healthy Adult SubjectsCompletedNCT01762995Phase 1
- Antiretroviral Therapy Adherence and Secondary Prevention of Human Immunodeficiency VirusCompletedNCT01760759Not applicable
- Alcohol Harm Reduction Intervention Among Female Sex Workers in Mombasa, KenyaCompletedNCT01756469Not applicable
- A Single Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of Intramuscular and Subcutaneous Long Acting GSK1265744 in Healthy SubjectsCompletedNCT01756131Phase 1
- A Trial to Assess the Functionality of Female Condom With a Silicone Elastomer Vaginal RingCompletedNCT01755754Phase 1
- Functionality of Male Condoms With a Silicone Elastomer Vaginal RIngCompletedNCT01755741Phase 1
- A Randomized Study to Assess the Relative Bioavailability of New Formulations of GSK1265744 Long Acting Parental (LAP) in Healthy Adult SubjectsCompletedNCT01754116Phase 1
- Behavioral Intervention to Enhance HIV Test/TreatCompletedNCT01752777Not applicable
- Connect to Protect (C2P): Building a Community-Based Infrastructure for HIV PreventionCompletedNCT01752504Not applicable
- The Feasibility of Using a General Health Screen to Increase HIV Testing in Community PharmaciesWithdrawnNCT01751100Not applicable
- Assessment of Cognitive Functioning as it Relates to Risk for Suicide in Veterans With HIV/AIDSCompletedNCT01749007
- Veterans Living With HIV/AIDS: A Pilot Study Examining Risk Factors Associated With Self-Directed ViolenceCompletedNCT01748968